Dovitinib
Drug timelines are a Plus or Pro feature.
35 regulatory and trial events tracked for Dovitinib, covering 2010-06-30 to 2025-05-07. Get the full timeline:
Most recent: Clinical Trial Update: Study to Determine the Maximum Tolerated Dose (MTD) of PARPi 2X-121 Monotherapy and the MTD of Dovitinib in Combination With 2X-121 in Patients With Advanced Solid Tumors [Phase 1]